Psychology & Psychiatry

Taxing sugary drinks curbs consumption, but only when pointed out

From sodas to sports drinks, sweetened beverages are a staple of the American diet, though this is not without consequences. Excessive consumption of sugary drinks is linked to a host of health problems, including diabetes, ...

Vaccination

France's Sanofi halts work on mRNA Covid vaccine

French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against COVID-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.

Diseases, Conditions, Syndromes

Turn the page on COVID-19? Not so fast, say experts

With global COVID cases declining and pandemic fatigue on the rise, many countries are easing restrictions put in place to block the spread of the virus.

Diseases, Conditions, Syndromes

Portugal fears a fourth wave from the Delta variant

Portugal fears a fourth wave of the coronavirus pandemic may take hold with the highly contagious Delta variant now accounting for more than 60 percent of new cases in the capital.

Vaccination

UK to require COVID-19 shots for nursing home workers

Britain will require COVID-19 vaccinations for nursing home workers in England, arguing that the need to protect vulnerable residents outweighed employees' right to choose whether to get the jab.

Vaccination

Brazil aims to buy 30 mn Sputnik V, Covaxin shots

The Brazilian government announced Wednesday it was negotiating the purchase of 30 million coronavirus vaccine doses from Russia and India, after regulators made it easier for the treatments to win emergency-use authorizations.

Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

Diseases, Conditions, Syndromes

Novavax enters late-stage clinical trials

US biotech firm Novavax said Thursday it was initiating its final Phase 3 clinical trial for its experimental COVID-19 vaccine.

page 1 from 3